IMVT – Immunovant Inc
IMVT — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
23.17
Margin Of Safety %
Put/Call OI Ratio
0.32
EPS Next Q Diff
0.04
EPS Last/This Y
0.19
EPS This/Next Y
0.2
Price
34.13
Target Price
44.6
Analyst Recom
1.62
Performance Q
25.55
Upside
-205.4%
Beta
0.74
Ticker: IMVT
22 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-04-23 | IMVT | 28.91 | 0.15 | 0.24 | 30522 |
| 2026-04-24 | IMVT | 28.55 | 0.15 | 0.00 | 30507 |
| 2026-04-27 | IMVT | 28.62 | 0.15 | 0.02 | 30556 |
| 2026-04-28 | IMVT | 26.97 | 0.15 | 0.51 | 30578 |
| 2026-04-29 | IMVT | 26.96 | 0.19 | 0.06 | 35571 |
| 2026-04-30 | IMVT | 27.14 | 0.19 | 0.43 | 35784 |
| 2026-05-01 | IMVT | 27.13 | 0.19 | 0.10 | 35796 |
| 2026-05-04 | IMVT | 27.85 | 0.19 | 0.00 | 36575 |
| 2026-05-05 | IMVT | 27.83 | 0.18 | 0.17 | 38242 |
| 2026-05-06 | IMVT | 28.69 | 0.18 | 0.13 | 38296 |
| 2026-05-07 | IMVT | 27.23 | 0.18 | 0.00 | 38417 |
| 2026-05-08 | IMVT | 28.97 | 0.17 | 0.02 | 39518 |
| 2026-05-11 | IMVT | 29.08 | 0.17 | 0.25 | 39741 |
| 2026-05-12 | IMVT | 28.65 | 0.17 | 0.00 | 39753 |
| 2026-05-13 | IMVT | 29.24 | 0.17 | 0.13 | 40346 |
| 2026-05-14 | IMVT | 28.99 | 0.17 | 0.54 | 39904 |
| 2026-05-15 | IMVT | 27.5 | 0.17 | 0.07 | 39404 |
| 2026-05-18 | IMVT | 26.53 | 0.05 | 0.05 | 22489 |
| 2026-05-19 | IMVT | 26.3 | 0.05 | 0.06 | 22933 |
| 2026-05-20 | IMVT | 35.55 | 0.05 | 0.55 | 23286 |
| 2026-05-21 | IMVT | 34.16 | 0.27 | 0.31 | 27935 |
| 2026-05-22 | IMVT | 34.13 | 0.32 | 0.26 | 27397 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-04-23 | IMVT | 28.89 | 3.4 | -33.3 | -2.53 |
| 2026-04-24 | IMVT | 28.59 | 3.4 | -27.2 | -2.53 |
| 2026-04-27 | IMVT | 28.63 | 3.4 | -27.9 | -2.53 |
| 2026-04-28 | IMVT | 26.97 | 3.4 | 6.0 | -2.53 |
| 2026-04-29 | IMVT | 26.96 | 3.4 | 6.3 | -2.53 |
| 2026-04-30 | IMVT | 27.16 | 3.4 | 2.3 | -2.53 |
| 2026-05-01 | IMVT | 27.11 | 3.4 | 3.3 | -2.53 |
| 2026-05-04 | IMVT | 27.87 | 3.4 | -12.3 | -2.53 |
| 2026-05-05 | IMVT | 27.84 | 3.4 | -11.8 | -2.53 |
| 2026-05-06 | IMVT | 28.67 | 3.4 | -29.1 | -2.53 |
| 2026-05-07 | IMVT | 27.23 | 3.4 | 0.7 | -2.53 |
| 2026-05-08 | IMVT | 28.96 | 3.4 | -34.7 | -2.53 |
| 2026-05-11 | IMVT | 29.07 | 3.4 | -36.9 | -2.53 |
| 2026-05-12 | IMVT | 28.61 | 3.4 | -27.6 | -2.53 |
| 2026-05-13 | IMVT | 29.24 | 1.9 | -40.5 | -2.53 |
| 2026-05-14 | IMVT | 28.98 | 1.9 | -35.1 | -2.53 |
| 2026-05-15 | IMVT | 27.49 | 1.9 | -4.6 | -2.53 |
| 2026-05-18 | IMVT | 26.55 | 1.9 | 14.7 | -2.53 |
| 2026-05-19 | IMVT | 26.29 | 1.9 | 0.9 | -2.53 |
| 2026-05-20 | IMVT | 35.51 | 1.9 | -168.9 | -2.53 |
| 2026-05-21 | IMVT | 34.15 | 1.9 | -147.2 | -2.53 |
| 2026-05-22 | IMVT | 34.13 | - | - | -2.58 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
22 items
«
‹
Current Page1 of 1
›
»
22 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-04-23 | IMVT | 16.08 | 5.70 | 22.20 |
| 2026-04-24 | IMVT | 15.89 | 5.70 | 22.20 |
| 2026-04-27 | IMVT | 15.90 | 5.91 | 23.49 |
| 2026-04-28 | IMVT | 15.90 | 5.91 | 23.49 |
| 2026-04-29 | IMVT | 15.90 | 5.91 | 23.49 |
| 2026-04-30 | IMVT | 15.90 | 5.91 | 23.49 |
| 2026-05-01 | IMVT | 15.90 | 5.91 | 23.48 |
| 2026-05-04 | IMVT | 15.90 | 5.75 | 23.48 |
| 2026-05-05 | IMVT | 15.90 | 5.75 | 23.48 |
| 2026-05-06 | IMVT | 15.90 | 5.75 | 23.48 |
| 2026-05-07 | IMVT | 15.90 | 5.75 | 23.48 |
| 2026-05-08 | IMVT | 15.90 | 5.75 | 23.48 |
| 2026-05-11 | IMVT | 15.90 | 6.38 | 23.48 |
| 2026-05-12 | IMVT | 15.90 | 6.38 | 22.38 |
| 2026-05-13 | IMVT | 15.90 | 6.38 | 22.38 |
| 2026-05-14 | IMVT | 15.90 | 6.38 | 22.38 |
| 2026-05-15 | IMVT | 15.90 | 6.38 | 22.38 |
| 2026-05-18 | IMVT | 15.90 | 6.39 | 22.38 |
| 2026-05-19 | IMVT | 15.90 | 6.39 | 22.38 |
| 2026-05-20 | IMVT | 15.90 | 6.39 | 22.38 |
| 2026-05-21 | IMVT | 15.89 | 6.39 | 22.38 |
| 2026-05-22 | IMVT | 15.75 | 6.39 | 23.17 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
22 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.67
Avg. EPS Est. Current Quarter
-0.62
Avg. EPS Est. Next Quarter
-0.63
Insider Transactions
15.75
Institutional Transactions
6.39
Beta
0.74
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
7
Growth Score
19
Sentiment Score
99
Actual DrawDown %
25.1
Max Drawdown 5-Year %
-78.3
Target Price
44.6
P/E
Forward P/E
PEG
P/S
P/B
8.17
P/Free Cash Flow
EPS
-2.77
Average EPS Est. Cur. Y
-2.58
EPS Next Y. (Est.)
-2.38
Target Price Estimates Raised
4
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.97
Return on Equity vs Sector %
-86.4
Return on Equity vs Industry %
-70.8
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.01
EBIT Estimation
◆
IMVT
Healthcare
$34.15
📉
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
8/20
Pullback
6/25
Volume
4/15
Valuation
8/20
TP/AR
2/10
Options
8/10
RSI
66.7
Range 1M
80.5%
Sup Dist
4.3%
🚀
Momentum Growth
Ride accelerating trends
WEAK
Momentum
15/25
Growth
6/30
Estimates
2/20
Inst/Vol
10/15
Options
8/10
EPS Yr
7.7%
EPS NY
2.3%
52W%
90.9%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+30.6% upside
Quality
2/30
Valuation
8/30
Growth
3/25
Stability
7/10
LT Trend
4/5
Upside
+30.6%
Quality
7
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Biotechnology
Employees: 315
Immunovant, Inc., a clinical-stage immunology company, develops targeted therapies to meet the needs of people with autoimmune diseases. It develops IMVT-1402, a human monoclonal antibody that inhibits neonatal fragment crystallizable receptor for graves' disease, rheumatoid arthritis, sjögren's disease, cutaneous lupus erythematosus disease, myasthenia gravis, and chronic inflammatory demyelinating polyneuropathy. The company was founded in 2018 and is based in Durham, North Carolina. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.
IMVT
Latest News
—
Caricamento notizie per IMVT…
stock quote shares IMVT – Immunovant Inc Stock Price stock today
news today IMVT – Immunovant Inc stock forecast ,stock prediction 2023 2024 2025
marketwatch IMVT – Immunovant Inc yahoo finance google finance
stock history IMVT – Immunovant Inc invest stock market
stock prices IMVT premarket after hours
ticker IMVT fair value insiders trading